NCT03972709 · Interventional trial
A Study Assessing the Safety, Tolerability, and Efficacy of Galegenimab (FHTR2163) in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration (AMD)
Overall registry status Terminated
Phase 2
Conditions Geographic Atrophy, Macular Degeneration, Age-Related
Delaware Valley sites
- Mid Atlantic Retina · Cherry Hill, NJ · Camden County
- Mid Atlantic Retina - Wills Eye Hospital · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory